467 followers
New article: Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis https://t.co/xFC4sQUNu2 #MS #multiplesclerosis #neurology https://t.co/7UOaYmd8XL